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Abstract
Objectives—Compare the impact of two worksite weight management programs, WM 
(education) and WM+ (education plus counseling), on health care utilization and costs. 
Secondarily, compare the intervention groups to an observational control group of obese workers. 
Finally, evaluate the impact of actual weight loss on these outcomes.
Methods—Estimate the change in the WM and WM+ intervention groups. Using propensity 
score adjustment compare the two intervention groups with the observational control group; and 
compare those who lost weight with those who did not.
Results—No significant differences between the two intervention groups, or between these 
intervention groups and the observational control group. Those who lost weight reduced their 
overall health care costs.
Conclusion—To achieve weight loss and associated morbidity reductions, more extensive and 
intensive interventions, with more attention to motivation and compliance, are required.
Keywords
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BACKGROUND
The health care costs of obesity are substantial,(1–4) and a large part of this cost is borne 
directly or indirectly by the employers of working-age adults.(5) One large study concluded 
that obese workers had 21% higher health care costs than those of recommended weight,(6) 
and that obesity, smoking, and stress were the costliest modifiable risk factors to the 
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employer-sponsored health plan.(7) A recent study found a gradual increase in health claims 
costs with each unit of BMI increase, and that specific obesity-related comorbid conditions, 
such as cardiovascular disease and musculoskeletal disease were the primary drivers of the 
cost increase.(8) While weight loss can reduce the risk of subsequent illness,(9) the impact 
of worksite intervention programs not only on weight loss, but also on health care utilization 
and costs, remains unclear.
Available evidence indicates that there is value in worksite weight loss programs.(10–15) In 
general, such programs reach individuals that otherwise may not have sought clinical 
intervention and yield short-term weight loss of 1–2 pounds per week,(12) with a few 
studies that have demonstrated sustained reduction in weight over the course of 1–2 years.
(11, 13, 16, 17) Unfortunately, few of these studies were randomized controlled trials 
(RCT). Of the RCTs that measured weight or BMI change in workplace programs, most 
were targeted at disease prevention and management (i.e., diabetes or cardiovascular 
disease),(13) and those that did show meaningful weight loss often had small sample sizes.
(18–20)
Less is known about the impact of worksite weight management programs on health care 
costs and utilization. Studies on employee wellness programs have shown reductions in 
health care utilization and costs for employees who use the programs.(21–24) A study by 
Borah et al.,(25) found decreases in weight with program participation also saw decreases in 
health care spending by employees, but that study did not specifically examine the impact of 
a weight management program. A study by Bilget et al.,(26) examining the effects of weight 
change did not show a reduction in health care costs for employees who lost weight, but that 
study was not an evaluation of a weight management program and only a 12% of their 
sample had a meaningful weight change during the study.
We undertook an evaluation of two worksite-based health promotion programs for obese 
workers at the second largest employer in North Carolina. One program was mostly 
educational (WM), while the other one was more intensive, and included one-on-one 
behavioral coaching (WM+).(27)
Results of the primary study outcome of weight loss by study arm have recently been 
published.(28) While there were no clinically, or statistically, meaningful differences 
between the two intervention groups in weight loss or weight related behaviors, there were 
modest reductions in body mass index, and positive, meaningful changes in diet and 
physical activity for both arms. Greater engagement in the intervention was associated with 
more weight loss in both arms. Predictors of engagement were younger age, lower baseline 
BMI, and randomization to the WM+ arm. There were also positive changes in the 
secondary outcomes of diet and physical activity measures between baseline and follow-up.
In addition to data collected through the evaluation study itself, we also analyzed data on 
health care utilization and costs for the two groups of workers taking part in the 
interventions as well as for an observational comparison group of obese workers not taking 
part in either intervention. The primary aim of the current analyses was to determine the 
relative impact of WM and WM+ on health care utilization and costs, overall, by type of 
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claims (inpatient, outpatient, pharmacy), and, specifically, for those classes of claims most 
likely to be “obesity related”.(8) We used a “difference-in-difference” analytical approach, 
comparing the difference between the two intervention groups in the change in these 
outcomes from the two year period prior to the intervention to the two years after the 
intervention. In secondary analyses, we combined the two groups of intervention 
participants and compared their outcomes to outcomes in the observational control group of 
obese workers not participating in either of the interventions. Finally, we evaluated the 
impact of actual weight loss on health care utilization and costs.
METHODS
Study Population Definition
The primary study groups were employees who participated in either the Weight 
Management (WM) or the Weight Management Plus (WM+) study arm as part of the Steps 
to Health study.(27) Obese (body mass index ≥30) employees at Duke were randomized 1:1 
to the two weight management programs. The WM program is primarily educational, while 
WM+ also incorporates behavioral coaching sessions. Both programs were delivered to the 
participants by trained health coaches. The programs were each approximately 12 months in 
length, but the number and method of contacts between the two programs varied. In WM 
employees received a face-to-face meeting with their coach in the first month, had follow-up 
coaching calls in months 6 and 12, and received monthly mailings of health education 
materials. In WM+ employees received monthly counseling sessions (face-to-face in months 
1, 4, 8, and 12, and the rest via telephone), as well as meetings with an exercise physiologist 
in months 2 and 5. They also received quarterly biometric feedback and targeted health 
education materials. Trained staff measured heights and weights using a Seca portable 
stadiometer (baseline only) and a Tanita BWB-800 scale (at all time points), and these 
measurements were used to calculate body mass index (BMI). To be eligible for the current 
analysis, participants also must have been enrolled in one of the health insurance programs 
offered through Duke for a minimum of 9 months in the 12 months prior to randomization 
and for a minimum of one month following their scheduled completion of the study 
intervention.
The study design also included a third group: an observational control group of employees 
who completed a health risk appraisal (HRA) between the dates of the first and last 
randomization of study participants (January 2011 and July 2012) with a BMI ≥30, but who 
did not participate in one of the weight management programs.
Employees were excluded from these analyses if they had bariatric surgery, an organ 
transplant, end stage renal disease, HIV/AIDS, or hemophilia.(29–31)
The overall study design is illustrated in Figure 1.
Data Sources
In addition to data collected specifically through the Steps to Health Study, most data used 
for the current analyses were obtained through the Duke Health and Safety Surveillance 
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System (DHSSS).(32) The extracted DHSSS data included all medical claims (inpatient and 
outpatient), pharmacy claims, and employee demographic and work-related variables.
Health Care Utilization and Cost Outcome Measures
Health care utilization measures include mean monthly rates for emergency room visits, 
hospital admissions, and days of stay in the hospital. Utilization rates are expressed here as 
mean events per 1000 months of health plan participation. For each study period (pre- and 
post-intervention) individual utilization rates were calculated as the sum of events, divided 
by the number of months of insurance plan participation during the time period.
Analyses included all claims and costs incurred including costs paid by the insurance plan as 
well as deductibles and copays incurred by the two study group participants and the 
observational controls. Claims for illnesses unlikely to benefit from study participation 
during the study time window (i.e. s, fertility treatments,, trauma, and burns) were excluded 
based on Healthcare Cost and Utilization Project (HCUP) Clinical Classification System 
(CCS) diagnosis groupings.(29) All costs were adjusted to 2013 dollars using the BLS 
Medical Care Consumer Price Index (CPI).(33) Categories of expenditures included mean 
monthly inpatient and outpatient medical inpatient costs, pharmacy costs, and total costs 
(pharmacy plus medical). Medical costs were further categorized by Major Diagnostic 
Category (MDC) and drug costs were further categorized by general therapeutic class based 
on the National Drug Code (NDC) using Redbook classifications. Classification procedures 
and the choice of MDC and drug categories for these sub-analyses were based on significant 
associations with BMI observed in our prior work.(8)
Comorbidities and Propensity Score
Medical and pharmacy claims during the 12 months of insurance coverage prior to the index 
date (randomization date for study subject or HRA date for controls) were used to calculate 
several measures of disease prevalence and co-morbidity. Individual prevalent health 
conditions at baseline commonly associated with obesity (coronary artery disease, 
congestive heart failure, diabetes, hypertension, depression, and peripheral vascular disease) 
were identified using the HCUP CCS(29), Elixhauser comorbid conditions(34), or the 
National Committee for Quality Assurance (NCQA) HEDIS classification system.(35, 36)
Two baseline summary measures of comorbidity were calculated: the combined Chronic 
Illness and Disability Payment System (CDPS) and the Medicaid Rx system (MRX)(37), 
and the Elixhauser comorbidity measure.(34, 38)
To compare the intervention groups to those not taking part in the interventions, we used 
propensity adjustment to balance risk factors and covariates.(39) Propensity adjustment 
using a regression model is designed to simulate results that might be obtained from a 
randomized control trial,(40) the assumption is that by conditioning on the propensity score 
systematic differences between treated and untreated subjects are eliminated. The propensity 
score includes demographic variables (age, gender, and race/ethnicity), health factors (BMI, 
smoking status), occupational group, and comorbidity scores. For a full list of the included 
variables in the propensity score see appendix 1.
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Covariate balance achieved using the propensity score was assessed by calculating the 
standardized differences between the intervention arm (WM and WM+) and the controls, for 
each covariate.(41) We considered absolute standardized differences less than 0.10 as an 
indication that adequate covariate balance was achieved.(42)
Analyses
Descriptive analyses were used to compare baseline characteristics of study participants and 
observational controls. Continuous variables were compared by ANOVA, and any variables 
that departed significantly from normal distribution were compared using the Wilcoxon 
rank-sum test. Dichotomous or categorical variables were compared using the chi-square 
test of general association.
We calculated mean utilization and costs by study arm and time period as an initial 
comparison (using an intent-to-treat approach). Effects of study participation on mean 
monthly health care utilization and costs relative to the observational controls were 
estimated using a difference-in-difference regression approach. Our initial model compared 
those randomized to the WM+ or WM study arms and did not include a propensity score as 
this was a randomized trial. The comparison of the combined study arm (WM and WM+) to 
the observational controls used similar models with propensity score adjustment for baseline 
covariates.
The parameter for the interaction of study arm with follow-up period is the desired 
difference-in-difference parameter estimate. We used a repeated measures negative binomial 
model with a log link function based our prior analyses of obesity related costs among this 
employee population.(28) In order to account for potentially correlated outcome data, all 
models were based on use of generalized estimated equations (GEE) assuming an 
exchangeable correlation structure, also based on our prior analyses.
We also compared the pre and post-intervention utilization and costs among WM+ and WM 
participants based on change in BMI during the intervention. Individuals in the WM+ or 
WM were classified as those losing weight and those not losing or even gaining weight 
during the intervention. Effects of weight loss on mean monthly health care utilization and 
costs relative to the observational controls were estimated using an approach similar to that 
used for the primary analyses. These analyses employed repeated measures negative 
binomial models with a log link function with direct adjustment for age, gender, race/
ethnicity, smoking status at baseline, BMI at baseline, and baseline comorbidities. Some 
cost and utilization categories were combined for these sub-analyses for greater model 
stability.
All statistical analyses were conducted using SAS 9.3.(43)
RESULTS
Table 1 presents sample characteristics for the study by arm. Data from a total of 420 
obesity study participants was used in these analyses (n=211 in WM, and 209 in WM+), and 
data from an additional 923 observational controls were used (see Figure 2 for a CONSORT 
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diagram). Participants in either study arm were younger than the observational controls 
(mean age was 43.7 in WM, 43.5 in WM+, 45.1 in controls, p=0.01), less likely to have 
diabetes (6.2% in WM, 12.9% in WM+, 28.5% in controls, p<0.001), less likely to have 
hypertension (27.0% in WM, 20.1% in WM+, 30.0% in controls, p=0.015), had a lower 
Elixhauser Comorbidities Index (0.96 in WM, 0.97 in WM+, 1.19 in controls, p=0.0005), 
and less likely to have participated in any disease management programs offered in the 
workplace (21.8% in WM, 18.7% in WM+, 29.0 in controls, p=0.001). There were also 
differences in the sample distribution by race, or smoking status. After propensity score 
adjustment standardized differences were less than 0.10 for all covariates included in the 
propensity score except the Elixhauser Comorbidities Index. Details of propensity score 
covariates and evaluation can be found in the online supplemental materials.
There were no significant differences in the change in health care costs or utilization 
between the two study arms (Table 2). Since there were no significant differences, we 
combined participants in the WM and WM+ arms for subsequent analyses.
When we compared the combined study participants to the observational controls in 
propensity score adjusted models we also found no significant differences between the 
intervention groups and the observational group on changes in health care costs or utilization 
(Table 3).
Finally, we explored the relationship between weight loss and changes in health care costs or 
utilization in the study participants (Table 4). We found that 355 of 420 study participants 
had a weight data available at the immediate post-intervention time point. Of those, 197 
people had a measured weight loss; the rest had either no change or had gained weight since 
the pre-intervention assessment. In covariate adjusted regression difference-in-difference 
models employees who lost weight had a reduction in their mean monthly total costs (from 
$554 to $434), while those who did not lose weight had an increase in total costs (from $441 
to $512). Essentially, those who lost weight reduced their monthly health care costs by $191 
more than those who did not (p=0.049). This was primarily driven by the medical claims 
costs ($203 reduction, p=0.023), rather than pharmacy claims costs ($11 reduction, 
p=0.322). In particular, there was a marked reduction in costs for obesity related MDCs for 
those who lost weight (from $204 to $131), and again an increase for those who did not lose 
weight (from $135 to $171), that represents a mean reduction of $108 monthly for weight 
loss (p=0.017).
DISCUSSION
The results of the current analyses show that there were no significant differences in health 
care utilization or costs between the two intervention groups, or between the intervention 
groups and the observational control group in adjusted analyses. However, those who 
actually lost weight, regardless of group, reduced their overall health care costs, particularly 
in outpatient costs and costs of obesity related illness.
While bariatric surgery and to a lesser extent pharmaceutical treatment can reduce weight, 
these options have risk of side effects and are costly. Behavioral interventions conducted as 
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part of RCTs to date, especially in obese individuals who are not highly motivated, have 
variable results but, usually have not been highly successful, either in terms of weight loss or 
in terms of impact on health care costs.(10, 15, 44, 45) This is true both in general,(46–48) 
and for interventions based in the workplace specifically.(30, 45) Our study of two 
workplace weight management programs is consistent with this pattern. The modest positive 
effects of weight loss on behaviors and the lack of impact on health care costs and utilization 
observed in this study indicate that to achieve weight loss through a worksite program, and 
in particular morbidity reductions strong enough to impact employer health costs, more 
extensive and intensive interventions are required, with more attention to motivation and 
compliance. Such interventions may include changes in the work environment,(15) social 
support in the form of group session(49) or competitions,(50, 51) or more frequent in-person 
contacts.(52)
Additional factors should be considered and included in future interventions and studies. 
Qualitative data from interviews and/or focus groups with participants and study personnel 
could provide context for why some participants were more successful at losing weight 
resulting in reduced overall healthcare costs. Identification of facilitators and barriers(48, 
53) to participation and adherence could inform changes needed to engage participants and 
elicit greater weight loss.
These analyses also illustrate the utility of the comprehensive workers health information 
systems capturing longitudinal data such as the Duke Health and Safety Surveillance 
System.
Strengths and limitations
The strengths of the Steps to Health study include the relatively large sample size, the racial 
diversity of the sample, and the use of a randomized control study design. Although all data 
are from this one employer, this employer is the second largest in North Carolina, and the 
results should be broadly generalizable to the adult working population given the breadth 
and diversity of the workers in terms of gender, age, and race/ethnicity. The use of both 
medical and pharmacy claims data further strengthens the findings. Another strength of this 
study is that it evaluated two established programs in the workplace that had support from 
management.
While the study attempted to capture a broad spectrum of factors that may evidence change, 
this resulted in potentially high participant burden. The participants were invited into the 
study – i.e. their motivation was likely not as strong as for those who seek out weigh loss 
programs on their own accord. We also conducted a number of statistical comparisons.
Implications and Conclusions
The modest positive effects of weight loss and behaviors and the lack of impact of 
assignment to two weight management programs on health care costs and utilization 
observed in this study, and in the earlier published analysis of this data,(8) indicate that to 
achieve weight loss through the work place, and in particular morbidity reductions strong 
enough to impact employer health costs, more extensive and intensive interventions are 
required, with more attention to motivation and compliance.
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Appendix 1
Covariates Included in the Propensity Score Logistic Model
Covariate Data Type Description
Age Continuous Age at baseline start
Gender Dichotomous Male, Female
Race/Ethnicity Categorical White, Black, Other
Body Mass Index (BMI) Continuous BMI at cohort entry
Cohort Entry Year Categorical Year of cohort entry
Cigarette Smoking Status Categorical Never, past, current smoker
Health Plan Type Categorical Employer health plan
Occupational Group Categorical Employee job group
Comorbidity Risk Score Continuous CDPS-Rx Summary Score
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Covariate Data Type Description
Elixhauser Comorbidity Index Continuous Count of Elixhauser Risks
CDPS-Rx Category
    Anti_coagulants
    Cancer_high
    Cancer_low
    Cardiac
    Cardiovascular_ex_low
    Cardiovascular_low
    Cardiovascular_medium
    Cerebrovascular_low
    CNS_low
    Diabetes
    Diabetes_type2_low
    Diabetes_type1_medium
    Diabetes_type2_medium
    Eye_low
    Eye_very_low
    Gastro_low
    Gastro_medium
    Genital_extra_low
    Hematological_medium





















Dichotomous for each 
CDPS-Rx category
CDPS-Rx condition or disease category using combined
ICD-9 diagnoses and pharmacy data using
CDPS-Rx Version 5.3. Only CDPS-Rx categories that had 
five or more prevalent cases in the combined cohort of 
obesity study participants and controls were included.
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Table 1











Mean Age in years (SE) 43.5 (0.66) 43.7 (0.66) 45.1 (0.34) 0.005
% Male 15.3 17.1 20.6 0.058
Race/Ethnicity (%) 0.012
  White 38.3 46.9 51.4
  Black 59.3 51.7 46.8
  Other 2.4 1.4 1.8
Obesity-Related Disease Prevalence (%)
  Diabetes 12.9 6.2 28.5 <0.001
  Hypertension 20.1 27.0 30.0 0.015
  Coronary Artery Disease 1.4 2.8 2.0 0.816
  Congestive Heart Failure 1.0 0.0 0.7 0.701
  Peripheral Vascular Disease 1.0 1.4 0.5 0.200
  Depression 8.1 10.0 9.0 0.974
Mean CDPS_Rx Risk Score (SE) 2.40 (0.05) 2.40 (0.05) 2.50 (0.03) 0.052
Mean Elixhauser Comorbidities (SE) 0.97 (0.08) 0.96 (0.07) 1.19 (0.04) 0.001
Mean BMI [kg/m2] (SE) 37.1 (0.43) 37.0 (0.41) 36.9 (0.21) 0.707
Occupational Group (%) 0.873
  Administrative and Managerial 10.6 16.6 16.4
  Clinical Technical/Professional 1.4 1.0 0.8
  Faculty/Clinical/Professional 8.2 8.1 6.5
  Nurse Aides/Medical Assistant 4.8 3.8 4.6
  Nursing/Nurse Managers 12.0 11.4 12.6
  Office Support 34.6 28.9 28.7
  Scientific/Electronic/Research Technology 9.1 16.1 12.7
  Service 13.5 9.5 11.6
  Skilled Crafts 1.9 1.9 2.2
  Technical/Clinical Labs 2.4 1.9 2.2
  All Other 1.4 1.0 2.0
Smoking Status (%) 0.011
  Never 68.9 66.4 65.6
  Past 26.3 29.9 25.8
  Current 4.8 3.8 8.9
























Health Plan (%) <0.001
  A 16.2 15.2 7.6
  B 6.2 5.7 3.5
  C 8.6 7.1 5.4
  D 65.1 65.1 82.3
  Missing 3.8 3.8 1.2
Mean Months of Baseline Health Insurance (SE) 11.92 (0.03) 11.90 (0.03) 11.96 (0.01) 0.034
Disease Management Program Participation (%) 18.7 21.8 29.0 0.001
High Cost Individuals (%)3 1.91 0.95 0.87 0.388
1
The baseline period for these analyses includes the 12 months prior to study entry.
2
P-value comparing obesity study participants (WM and WM+) as described in methods
3
Individuals with >$100,000 costs per year in any follow-up period.
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